Aktie A2PXSS CHINA BIOTECH SERVICES HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Biotech Services Holdings Limited

Aktien

A2PXSS

BMG2152F1014

8037

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:06 30.04.2024 		% 5 Tage % 1. Jan.
0,29 HKD +7,41 % Intraday Chart für China Biotech Services Holdings Limited +9,43 % -62,34 %
28.03. China Biotech Services Holdings Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
28.02. China Biotech Services Holdings Limited gibt ungeprüfte konsolidierte Gewinnprognose für das Jahr bis zum 31. Dezember 2023 ab CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Biotech Services Holdings Limited announced that it expects to receive HKD 88 million in funding
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
China Biotech Services Holdings Limited announced that it has received HKD 77.8 million in funding from Guoyuan Securities Investment (Hong Kong) Limited
China Biotech Services Holdings Limited Announces Board Changes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PXSS Aktie
  4. Nachrichten China Biotech Services Holdings Limited
  5. Andere Sprachen